Taken together, these translational studies provide initial evidence that proteolytic activity of MMP12 secreted by macrophages that are activated on mucostatic airway surfaces may contribute to the pathogenesis of structural lung damage and lung function decline in patients with CF [52]. This evidence concerns the gene MMP12 and cystic fibrosis.